European Association for Cancer Research (EACR)

Dr. Xue-Yan He discusses her recent research on the impact of stress on the tumour microenvironment in our latest podcast episode 🎧 https://lnkd.in/erGKVcp9

Early-stage, curiosity-driven cancer research is the cornerstone of future medical breakthroughs. Let's #KeepResearchCurious ✨ https://lnkd.in/eqc_NBEJ

As someone entering the world of #LiquidBiopsy, a couple thoughts that stuck with me following the European Association for Cancer Research (EACR) LB conference: 📈 Living in a world hyped on the power of data, it is tempting to dive straight into hot-off-the-bench datasets to extract a wealth of information. The LB community stressed the significance of pre-analytics and the impacts on downstream analyses: 🔹 Did the sample prep bias the genomic composition? (Daniel Hagey on ligation vs. fragmentation amplification approaches; An Hendrix's call for SOP) 🔹 Has sample time collection introduced bias? (Nicola Aceto's findings on the wave-like release of analytes rather than continuous stream) ❓ The growing interest in EVs and all the budding questions that arise - Widely ranging in sizes, which do we investigate? When are EVs released? How do we differentiate EVs derived from normal vs. tumour cells? How can the analyses of both inform on tumour states and TME? 🦠 Then swooping in with prokaryotic insights, Shang Cai spoke about the presence of bacteria in CTC clusters, highlighting enhanced tumour cell capabilities for immune evasion, withstanding mechanical stress during shedding and overall tumour metastasis 🍼 Cristina Saura Manich's research on the concordance of ctDNA analyses from breast milk vs. plasma and highlighting the identification of actionable mutations enabled only by the prior, for early detection of breast cancer in postpartum women 🥼 Lastly, Valsamo Anagnostou's leading work to implement and demonstrate the various utilities of liquid biopsy in the clinical setting, capturing ctDNA dynamics through her Tic Tac Toe trial for patients with NSCLC Thanks #EACR for organising a conference so diverse and engaging in talks and welcoming for both experts and newcomers. Hope to be back!

Submit your abstract by 13 January for our upcoming virtual conference! Join us in exploring the systemic consequences of cancer: https://lnkd.in/enCN272G

"Scientists can now use AI to consider numerous factors like genome, proteome, environmental factors, and patient history to predict tumour growth and drug response..." EACR member Aisha Shigna Nadukkandy writes about the potential of AI to revolutionise cancer research in her shortlisted article for the EACR Science Communication Prize 2024: https://lnkd.in/efEw76eH #KeepResearchCurious

Don't miss our next Industry Webinar with Menarini Silicon Biosystems! Prof Paola Gazzaniga will discuss advances in the field of cell based liquid biopsy using the gold-standard CELLSEARCH System® for circulating tumour cells analysis. 📅 05 December 🕓 15:00 CET 🌍 Zoom ➡️ https://lnkd.in/eSM-faiD

Exciting news, EACR members! René Bernards' recent webinar discussing his significant research into the MAP kinase pathway is now available to watch on-demand: 📼 https://lnkd.in/eRS9C3Dn

We know a lot of the #CancerResearch community are dipping their toes in the waters of Bluesky Social and hoping to build a network on the platform moving forward 🦋 find us by searching helloeacr! helloeacr.bsky.social

One of our most popular conferences is back for 2025 🎉 After a sold-out 2023 event, Goodbye Flat Biology has moved to a larger venue in Essen, Germany to make sure more of you can join us for what promises to be another fantastic event. Join your fellow cancer researchers for 3 days of excellent science and networking in this exciting field: https://lnkd.in/eEw8NM4G

Yesterday some of the members of the EACR Advisory Board met for an exciting discussion about the future direction of the EACR, focusing on emerging areas of scientific interest and the benefits we provide to our members 🤩 Marta Puyol Fundación Científica de la Asociación Española Contra el Cáncer Anton Berns The Netherlands Cancer Institute Elaine Mardis Nationwide Children's Hospital Richard Marais Oncodrug Ltd Carl-Henrik Heldin Ludwig Cancer Research Moshe Oren Weizman Institute of Science Olli Kallioniemi SciLifeLab